Datroway gets FDA nod
Datroway's treatment for triple-negative breast cancer receives FDA approval, potentially expanding treatment options. This may impact related biotech stocks.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.